Latest Insider Transactions at Tcr2 Therapeutics Inc. (TCRR)
This section provides a real-time view of insider transactions for Tcr2 Therapeutics Inc. (TCRR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TCR2 THERAPEUTICS INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TCR2 THERAPEUTICS INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2023
|
Tang Kevin C |
SELL
Other acquisition or disposition
|
Indirect |
4,394,800
-100.0%
|
-
|
|
Jun 01
2023
|
Ansbert Gadicke Director |
SELL
Other acquisition or disposition
|
Indirect |
7,529,946
-100.0%
|
-
|
|
Jun 01
2023
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
4,158,964
-100.0%
|
-
|
|
Jun 01
2023
|
Mpm Sun States Fund, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
4,158,964
-100.0%
|
-
|
|
Jun 01
2023
|
Ubs Oncology Impact Fund L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
3,370,982
-100.0%
|
-
|
|
Jun 01
2023
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
109,459
-100.0%
|
-
|
|
Jun 01
2023
|
Peter Olagunju Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,092
-100.0%
|
-
|
|
Jun 01
2023
|
Angela Justice Chief People Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
48,745
-100.0%
|
-
|
|
Jun 01
2023
|
Garry E Menzel President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
138,871
-100.0%
|
-
|
|
Jun 01
2023
|
Garry E Menzel President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
265,459
-100.0%
|
-
|
|
May 25
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
50,000
+1.12%
|
$50,000
$1.72 P/Share
|
|
May 22
2023
|
Ansbert Gadicke Director |
SELL
Open market or private sale
|
Indirect |
70,170
-18.75%
|
$70,170
$1.88 P/Share
|
|
May 22
2023
|
Ansbert Gadicke Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
178,269
+32.27%
|
$0
$0.74 P/Share
|
|
May 22
2023
|
Mpm Asset Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
70,170
-18.75%
|
$70,170
$1.88 P/Share
|
|
May 22
2023
|
Mpm Asset Management LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
178,269
+32.27%
|
$0
$0.74 P/Share
|
|
May 12
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
6,183
+0.14%
|
$6,183
$1.95 P/Share
|
|
May 11
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
38,765
+0.89%
|
$38,765
$1.95 P/Share
|
|
May 10
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
6,774
+0.16%
|
$6,774
$1.95 P/Share
|
|
May 09
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
20,141
+0.47%
|
$20,141
$1.95 P/Share
|
|
May 08
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
57,073
+1.32%
|
$57,073
$1.95 P/Share
|
|
May 05
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
166,823
+1.96%
|
$166,823
$1.92 P/Share
|
|
May 04
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
104,241
+2.51%
|
$104,241
$1.86 P/Share
|
|
May 03
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
18,513
+0.47%
|
$18,513
$1.85 P/Share
|
|
Dec 13
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-7.34%
|
$11,000
$1.06 P/Share
|
|
Dec 13
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,659
-6.44%
|
$1,659
$1.06 P/Share
|
|
Dec 13
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,752
-4.16%
|
$4,752
$1.06 P/Share
|
|
Dec 12
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
10,613
-6.61%
|
$10,613
$1.1 P/Share
|
|
Dec 12
2022
|
Angela Justice Chief People Officer |
SELL
Open market or private sale
|
Direct |
5,828
-5.49%
|
$5,828
$1.08 P/Share
|
|
Dec 12
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,610
-5.88%
|
$1,610
$1.1 P/Share
|
|
Dec 12
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,586
-3.86%
|
$4,586
$1.1 P/Share
|
|
Dec 09
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
10,325
-6.04%
|
$10,325
$1.13 P/Share
|
|
Dec 09
2022
|
Angela Justice Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,792
-4.87%
|
$2,792
$1.13 P/Share
|
|
Dec 09
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,561
-5.4%
|
$1,561
$1.13 P/Share
|
|
Dec 09
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,461
-3.62%
|
$4,461
$1.13 P/Share
|
|
Dec 08
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,410
-4.65%
|
$1,410
$1.25 P/Share
|
|
Dec 08
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
9,314
-5.17%
|
$9,314
$1.25 P/Share
|
|
Dec 08
2022
|
Angela Justice Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,511
-4.19%
|
$2,511
$1.25 P/Share
|
|
Dec 08
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,014
-3.15%
|
$4,014
$1.26 P/Share
|
|
Dec 07
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,378
-4.35%
|
$1,378
$1.28 P/Share
|
|
Dec 07
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
9,111
-4.81%
|
$9,111
$1.28 P/Share
|
|
Dec 07
2022
|
Angela Justice Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,457
-3.94%
|
$2,457
$1.28 P/Share
|
|
Dec 07
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,928
-2.99%
|
$3,928
$1.28 P/Share
|
|
Dec 06
2022
|
Angela Justice Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,361
-3.65%
|
$2,361
$1.33 P/Share
|
|
Dec 06
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
14,886
-7.29%
|
$14,886
$1.35 P/Share
|
|
Dec 06
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,327
-4.02%
|
$1,327
$1.33 P/Share
|
|
Dec 06
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,778
-2.8%
|
$3,778
$1.33 P/Share
|
|
Dec 05
2022
|
Angela Justice Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,302
-3.44%
|
$2,302
$1.37 P/Share
|
|
Dec 05
2022
|
Garry E Menzel President and CEO |
SELL
Open market or private sale
|
Direct |
8,530
-4.01%
|
$8,530
$1.37 P/Share
|
|
Dec 05
2022
|
Peter Olagunju Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,291
-3.76%
|
$1,291
$1.37 P/Share
|
|
Dec 05
2022
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,686
-2.66%
|
$3,686
$1.37 P/Share
|